Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Prevention of Osteoporosis in Men With Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				50 to 85				NIDDK				DK61535 NCT00048841

Last Modified: 6/2/2008 First Published: 7/14/2006


2.		Phase III Companion Study of Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Treated on Protocol CAN-NCIC-MA27

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Natural history/Epidemiology, Supportive care				Closed				45 and over				NCI				CAN-NCIC-MA27B NCIC-MA.27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, NCT00354302, MA27B

Last Modified: 10/20/2007 First Published: 5/1/1999


3.		Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-99-C-0052 NCT00019695

Last Modified: 1/1/1991


4.		Randomized, Double-Blind, Multicenter Study of a Single Intravenous Dose of MK-217 vs Standard Etidronate Treatment in Patients with Malignancy-Associated Hypercalcemia (Summary Last Modified 01/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				over 18								MSKCC-90117 NCI-V90-0194

Last Modified: 8/1/1991


5.		Open-Label, Multicenter Study of a Single Intravenous Dose of MK-217 in Patients with Malignancy-Associated Hypercalcemia and Moderately Severe Renal Insufficiency (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Completed				18 and over								MSKCC-91039 NCI-V91-0105

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute